SereNeuro Therapeutics (Pre-Seed)
Funding Details
Awarder
Inbox
Date Award
October 5, 2026
Vertical
Biotechnology
Funding URL
View Funding Page
Company Info
Founders
Daniel Saragnese
Market
Pain Management
Location
Baltimore, MD, USA
Company Description

SereNeuro Therapeutics is a preclinical-stage biotechnology company developing first-in-class non-opioid therapies for pain, including iPSC-derived neuron therapies and gene therapies, led by SN101.

Links
Website
Back to HomeBack to Biotechnology DealsView Funding Announcement